Global Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

CSAR Subsidiary Regulation: China Consults on Administrative Measures on Cosmetics Inspection

Administrative Measures on Cosmetics Inspection systematically clarifies the requirements about cosmetic inspection categories, inspection procedures, link between inspection and audit, and result handling.

On October 19, 2023, China National Medical Products Administration (NMPA) solicited opinions on Administrative Measures on Cosmetics Inspection (hereinafter referred to as the "Measures"). 1 Suggestions can be submitted via email to [email protected] until November 10.

The Measures represents the first system construction by NMPA aimed at comprehensively standardizing cosmetics inspections since the implementation of the Cosmetic Supervision and Administration Regulation (CSAR). With 8 chapters and 46 articles, the Measures systematically clarifies the requirements for inspection categories, inspection procedures, link between inspection and audit, and result handling. It aims to address the main problems currently faced in cosmetics inspection work.

Applicable Scope

The Measures applies to the following areas:

1. Inspection of:

  • Registration and notification of new cosmetic ingredients (NCIs);

  • Registration and notification of cosmetic products;

  • Toothpaste notification;

  • Extension inspections conducted by medical products administration departments on suppliers and manufacturers of cosmetic ingredients and primary packaging materials, as required for regulatory purposes.

2. Inspection of toothpaste production and operation.

Clarifying Inspection Categories and Inspection Requirements

Cosmetics inspections are categorized into four types as below, based on their nature and purpose.

1. Licensing inspection

2. Routine inspection

3. Cause-based inspection

4. Other inspections

Each type of inspection has specific requirements for the inspection’s initiation, focus, and methods.

Inspection Categories and Focus

Inspection Categories

Introduction

Inspection Focus

Licensing Inspection

During the cosmetics production licensing process, the medical products administration department conducts inspections to assess whether the applicant meets the conditions outlined in laws and regulations. The inspection is divided into:

 

  • On-site inspection for the issuance of the production license;

  • On-site inspection after the renewal of the production license;

  • On-site inspection for changes to the production license.

All items specified in Attachment 1 of Inspection Points and Judgment Principles of Cosmetic Good Manufacturing Practices

Routine Inspection

The medical products administration departments are responsible for conducting scheduled inspections based on their annual work points to assess the compliance of inspection objects with laws and regulations, mandatory national standards, and technical specifications.

 

The primary inspection objects include children's cosmetics, special cosmetics, cosmetics added with NCIs during the monitoring period, cosmetic manufacturers, and e-commerce platform operators with significant cosmetics transaction volume. Various factors are taken into account during the selection of inspection objects, such as cosmetics registration and notification, sampling inspection, adverse reaction monitoring, risk monitoring, complaint reporting, case investigation and handling, and public opinion monitoring.

Cosmetics registrant, notifier, and entrusted production enterprise

All or specific key items specified in Inspection Points and Judgment Principles of Cosmetic Good Manufacturing Practices

Operation process

Whether a purchase inspection and recording system has been established and implemented

Cause-based Inspection

Targeted inspections are conducted on inspected objects based on risk information obtained from registration and notification, sampling inspection, adverse reaction monitoring, risk monitoring, complaints and reports, and public opinion monitoring.

 

The medical products administration department may conduct cause-based inspections of cosmetics manufacturers and operators under the following circumstances:

 

  • Sampling inspection, adverse reaction monitoring, and/or risk monitoring indicate quality and safety risks associated with the product;

  • Complaints, reports, and/or other sources suggest potential quality and safety risks;

  • Suspected violations of laws, regulations, mandatory national standards, and/or technical specifications;

  • Public opinion monitoring indicates the quality and safety of cosmetics may lead to a potential impact on the public perception;

  • Other situations that warrant cause-based inspections.

Whether there are any violations of laws and regulations, mandatory national standards, and/or technical specifications

Inspection Results

Upon reviewing the inspection results and following the risk management principles, the medical products administration department may implement appropriate measures, such as imposing a deadline for rectification, ordering the suspension of production and operations, ordering product recalls, conducting legislative investigations, conducting responsibility interviews, and recording the situation in credit files.

ChemLinked expects to assist companies in registering/notifying cosmetics in China. If you have any further cosmetic compliance consultation needs, please contact us at [email protected].

BANNER 810 150  gif.gifFurther Reading

We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by [email protected]
Copyright: unless otherwise stated all contents of this website are ©2026 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact [email protected]
User Guide